FindMyRecallSubscribe
Class I: serious health riskTerminated

Endo Pharmaceuticals robaxin-750 Recall

robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distribute…

Endo Pharmaceuticals, Inc. · Malvern, PA

Risk level
Class I
Reported by FDA
Oct 10, 2018
Recall ID
D-0009-2019
Check your lot numberHow we source this data

Summary

Endo Pharmaceuticals recalled robaxin-750 starting Sep 17, 2018. The FDA classified it as Class I (serious health risk) and published enforcement report D-0009-2019 on Oct 10, 2018. Reason: Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily.". Status: Terminated.

Why it was recalled

Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."

Product description

robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10.

Lot numbers, UPCs & expiration codes

Lot #: 216702P1, Exp 09/20; 220409P1, Exp 01/21

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0009-2019
Classification
Class I
Status
Terminated
Recall initiated
Sep 17, 2018
FDA report date
Oct 10, 2018
Quantity
2,856 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Endo Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0009-2019, exactly as published.

Show all FDA fields
City
Malvern
State
PA
Status
Terminated
Country
United States
Event ID
81034
Address
1400 Atwater Dr
Code information
Lot #: 216702P1, Exp 09/20; 220409P1, Exp 01/21
Postal code
19355-8701
Report date
Oct 10, 2018
Product type
Drugs
Recall number
D-0009-2019
Classification
Class I
Recalling firm
Endo Pharmaceuticals, Inc.
Product quantity
2,856 bottles
Termination date
Feb 4, 2020
Reason for recall
Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."
Voluntary / mandated
Voluntary: Firm initiated
Product description
robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Sep 17, 2018
Initial firm notification
Letter
Center classification date
Oct 9, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0009-2019, published Oct 10, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls